Armistice Capital’s PetMed Express PETS Stock Holding History

Armistice Capital’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-532,000	Closed	-$17.6M	–	91
2018 Q3	$17.6M	Buy	+532,000	New	+$19.9M	1.05%	31

Other funds holding PETS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Armistice Capital's PETS Position: Q4 2018 in Review

Armistice Capital sold out of PetMed Express (PETS) in Q4 2018, closing a stake of 532,000 shares — an estimated $17.6M sold.

Armistice Capital first reported a position in PETS in Q3 2018 and held it in 1 quarter. The position peaked at $17.6M in Q3 2018. 200 funds tracked by Wall St. Rank hold PETS as of Q4 2018.

Armistice Capital reported no remaining PetMed Express position as of Q4 2018 after selling out during the quarter.
Armistice Capital sold 532,000 PetMed Express shares in Q4 2018, an estimated $17.6M.
Armistice Capital first reported a position in PetMed Express in Q3 2018 and held it in 1 quarter.
Armistice Capital's PetMed Express position peaked at $17.6M in Q3 2018.
200 funds tracked by Wall St. Rank held PetMed Express as of Q4 2018.

Based on Armistice Capital's 13F filing for Q4 2018, filed 14 Feb 2019.